Crossmark

Are direct oral anticoagulants an economically attractive alternative to low molecular weight heparins in lung cancer associated venous thromboembolism management?

Crossref DOI link: https://doi.org/10.1007/s11239-020-02047-1

Published Online: 2020-02-04

Published Print: 2020-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Howlett, Jennifer

Benzenine, Eric

Fagnoni, Philippe

Quantin, Catherine https://orcid.org/0000-0001-5134-9411
License Information

Text and Data Mining valid from 2020-02-04

Version of Record valid from 2020-02-04
More Information

Article History

First Online: 4 February 2020

Compliance with ethical standards

:

: The authors have no conflicts of interest relevant to this article to disclose.

Document is current

Any future updates will be listed below